Docetaxel administration schedule: From fever to tears? A review of randomised studies
- 31 May 2005
- journal article
- research article
- Published by Elsevier in European Journal Of Cancer
- Vol. 41 (8) , 1117-1126
- https://doi.org/10.1016/j.ejca.2005.02.016
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Participation in Cancer Clinical TrialsJAMA, 2004
- Randomized, Multinational, Phase III Study of Docetaxel Plus Platinum Combinations Versus Vinorelbine Plus Cisplatin for Advanced Non–Small-Cell Lung Cancer: The TAX 326 Study GroupJournal of Clinical Oncology, 2003
- Participation of Patients 65 Years of Age or Older in Cancer Clinical TrialsJournal of Clinical Oncology, 2003
- Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy RegimensJournal of Clinical Oncology, 2000
- Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based ChemotherapyJournal of Clinical Oncology, 2000
- Prospective Randomized Trial of Docetaxel Versus Doxorubicin in Patients With Metastatic Breast CancerJournal of Clinical Oncology, 1999
- Prospective Randomized Trial of Docetaxel Versus Mitomycin Plus Vinblastine in Patients With Metastatic Breast Cancer Progressing Despite Previous Anthracycline-Containing ChemotherapyJournal of Clinical Oncology, 1999
- Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer.Journal of Clinical Oncology, 1998
- Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis.Journal of Clinical Oncology, 1994
- The calculation of received dose intensity.Journal of Clinical Oncology, 1990